Creatinine clearance/eGFR ratio: a simple index for muscle mass related to mortality in ICU patients

被引:1
|
作者
Volbeda, Meint [1 ]
Zijlstra, Hendrik W. [1 ]
Post, Adrian [2 ]
Kootstra-Ros, Jenny E. [3 ]
van der Voort, Peter H. J. [1 ]
Franssen, Casper F. M. [2 ]
Nijsten, Maarten W. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, POB 30-001,EB70, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr, Dept Nephrol, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr, Dept Lab Med, Groningen, Netherlands
关键词
Estimated glomerular filtration rate; Creatinine clearance; Critically ill patients; Muscle mass; Sarcopenia; Urinary creatinine excretion; Mortality;
D O I
10.1186/s12882-024-03760-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction In patients admitted to the intensive care unit (ICU), muscle mass is inversely associated with mortality. Although muscle mass can be estimated with 24-h urinary creatinine excretion (UCE), its use for risk prediction in individual patients is limited because age-, sex-, weight- and length-specific reference values for UCE are lacking. The ratio between measured creatinine clearance (mCC) and estimated glomerular filtration rate (eGFR) might circumvent this constraint. The main goal was to assess the association of the mCC/eGFR ratio in ICU patients with all-cause hospital and long-term mortality. Methods The mCC/eGFR ratio was determined in patients admitted to our ICU between 2005 and 2021 with KDIGO acute kidney injury (AKI) stage 0-2 and an ICU stay >= 24 h. mCC was calculated from UCE and plasma creatinine and indexed to 1.73 m2. mCC/eGFR was analyzed by categorizing patients in mCC/eGFR quartiles and as continuous variable. Results Seven thousand five hundred nine patients (mean age 61 +/- 15 years; 38% female) were included. In-hospital mortality was 27% in the lowest mCC/eGFR quartile compared to 11% in the highest quartile (P < 0.001). Five-year post-hospital discharge actuarial mortality was 37% in the lowest mCC/eGFR quartile compared to 19% in the highest quartile (P < 0.001). mCC/eGFR ratio as continuous variable was independently associated with in-hospital mortality in multivariable logistic regression (odds ratio: 0.578 (95% CI: 0.465-0.719); P < 0.001). mCC/eGFR ratio as continuous variable was also significantly associated with 5-year post-hospital discharge mortality in Cox regression (hazard ratio: 0.27 (95% CI: 0.22-0.32); P < 0.001). Conclusions The mCC/eGFR ratio is associated with both in-hospital and long-term mortality and may be an easily available index of muscle mass in ICU patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients
    Bihari, Shailesh
    Holt, Andrew W.
    Prakash, Shivesh
    Bersten, Andrew D.
    JOURNAL OF CRITICAL CARE, 2016, 33 : 200 - 206
  • [42] Urinary creatinine excretion is related to short-term and long-term mortality in critically ill patients
    Lara Hessels
    Niels Koopmans
    Antonio W. Gomes Neto
    Meint Volbeda
    Jacqueline Koeze
    Annemieke Oude Lansink-Hartgring
    Stephan J. Bakker
    Heleen M. Oudemans-van Straaten
    Maarten W. Nijsten
    Intensive Care Medicine, 2018, 44 : 1699 - 1708
  • [43] Estimation of creatinine clearance using plasma creatinine or cystatin C: a secondary analysis of two pharmacokinetic studies in surgical ICU patients
    Steinke, Thomas
    Moritz, Stefan
    Beck, Stefanie
    Gnewuch, Carsten
    Kees, Martin G.
    BMC ANESTHESIOLOGY, 2015, 15
  • [44] Multidimensional Assessment of Sarcopenia and Sarcopenic Obesity in Geriatric Patients: Creatinine/Cystatin C Ratio Performs Better than Sarcopenia Index
    Khalil, Mohamad
    Di Ciaula, Agostino
    Jaber, Nour
    Grandolfo, Roberta
    Fiermonte, Flavia
    Portincasa, Piero
    METABOLITES, 2024, 14 (06)
  • [45] Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
    Shi, Shanshan
    Jiang, Yizhou
    Chen, Weihua
    Chen, Kaihong
    Liao, Ying
    Huang, Kun
    FRONTIERS IN NUTRITION, 2022, 9
  • [46] Muscle mass evaluation using psoas muscle mass index by computed tomography imaging in hemodialysis patients
    Ito, Kiyonori
    Ookawara, Susumu
    Imai, Sojiro
    Kakuda, Hideo
    Bandai, Yusaku
    Fueki, Mariko
    Yasuda, Masatoshi
    Kamimura, Tatsuya
    Kiryu, Satoshi
    Wada, Noriko
    Hamashima, Yuri
    Shindo, Mitsutoshi
    Kobayashi, Tadanao
    Sanayama, Hidenori
    Kaku, Yoshio
    Tanno, Keisuke
    Ohnishi, Yasushi
    Iino, Noriaki
    Dezaki, Katsuya
    Kakei, Masafumi
    Tabei, Kaoru
    Morishita, Yoshiyuki
    CLINICAL NUTRITION ESPEN, 2021, 44 : 410 - 414
  • [47] The impact of muscle mass and myosteatosis on mortality in critically ill patients with Sars-Cov2-related pneumonia
    Sabatino, Alice
    Pacchiarini, Maria Chiara
    Regolisti, Giuseppe
    Ciuni, Andrea
    Sverzellati, Nicola
    Lesignoli, Matteo
    Picetti, Edoardo
    Fiaccadori, Enrico
    Di Mario, Francesca
    CLINICAL NUTRITION ESPEN, 2023, 58 : 409 - 415
  • [48] Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia
    Huang, Sha
    Guo, Yan
    Chen, Lanlan
    Wang, Yan
    Chen, Xiaoyan
    BMC GERIATRICS, 2022, 22 (01)
  • [49] Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population-based cohort
    Groothof, Dion
    Shehab, Naser B. N.
    Erler, Nicole S.
    Post, Adrian
    Kremer, Daan
    Polinder-Bos, Harmke A.
    Gansevoort, Ron T.
    Groen, Henk
    Pol, Robert A.
    Gans, Reinold O. B.
    Bakker, Stephan J. L.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (04) : 1528 - 1538
  • [50] Muscle mass dynamics is independently associated with long-term liver-related mortality in patients with cirrhosis
    Zheng, Jiarui
    Yang, Shuo
    Ren, Wenhui
    Zhong, Juan
    Liu, Xin
    Han, Rui
    Wei, Tingyang
    Tie, Changjie
    Yang, Yuteng
    Hong, Chengwu
    Feng, Bo
    Huang, Rui
    HELIYON, 2024, 10 (15)